nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Japanese multi-institutional phase II study of moderate hypofractionated intensity-modulated radiotherapy with image-guided technique for prostate cancer
|
Nakamura, Katsumasa |
|
|
29 |
6 |
p. 847-852 |
artikel |
2 |
Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy
|
Sahin, Taha Koray |
|
|
29 |
6 |
p. 822-831 |
artikel |
3 |
A real-world study of treatment sequences and second-line clinical outcomes in patients with HER2-positive metastatic breast cancer in US community practice
|
Varghese, Della |
|
|
29 |
6 |
p. 780-789 |
artikel |
4 |
Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022
|
Yoshinami, Tetsuhiro |
|
|
29 |
6 |
p. 681-688 |
artikel |
5 |
Development and validation of a nomogram to predict overall survival in patients with redefined anaplastic thyroid carcinoma based on the SEER database
|
Zhang, Chuyue |
|
|
29 |
6 |
p. 744-754 |
artikel |
6 |
Early experience and future prospects regarding use of newly developed surgical robot system, hinotori, in the field of urologic cancer surgery
|
Miyake, Hideaki |
|
|
29 |
6 |
p. 640-646 |
artikel |
7 |
Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology
|
Ito, Mamoru |
|
|
29 |
6 |
p. 689-699 |
artikel |
8 |
English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical Oncology
|
Hirota, Seiichi |
|
|
29 |
6 |
p. 647-680 |
artikel |
9 |
Exploratory analysis of serum HER2 extracellular domain for HER2 positive gastric cancer treated with SOX plus trastuzumab
|
Wakatsuki, Takeru |
|
|
29 |
6 |
p. 801-812 |
artikel |
10 |
Favorable clinical efficacy of cytotoxic chemotherapy in patients with progressive desmoid tumors: a retrospective real-world study
|
Oh, Chung Ryul |
|
|
29 |
6 |
p. 853-861 |
artikel |
11 |
Impact of disease volume on survival efficacy of triplet therapy for metastatic hormone-sensitive prostate cancer: a systematic review, meta-analysis, and network meta-analysis
|
Matsukawa, Akihiro |
|
|
29 |
6 |
p. 716-725 |
artikel |
12 |
Local excision versus radical surgery for anal squamous cell carcinoma: a multicenter study in Japan
|
Murai, Shin |
|
|
29 |
6 |
p. 813-821 |
artikel |
13 |
Macroscopic type is implicated in the prognostic impact of initial chemotherapy on peritoneal lavage cytology-positive gastric cancer with no other noncurative factors
|
Kano, Yosuke |
|
|
29 |
6 |
p. 790-800 |
artikel |
14 |
MMP1, IL-1β, sTNFR-1, and IL-6 are prognostic factors for patients with unresectable or metastatic renal cell carcinoma treated with immune checkpoint inhibitors
|
Nagasaka, Hirotaka |
|
|
29 |
6 |
p. 832-839 |
artikel |
15 |
Optimal surgical approach for mid-transverse colon cancer: a systematic review and meta-analysis
|
Elkomos, Beshoy Effat |
|
|
29 |
6 |
p. 706-715 |
artikel |
16 |
PD-L1 expression and microsatellite instability (MSI) in cancer of unknown primary site
|
Junior, João Neif Antonio |
|
|
29 |
6 |
p. 726-734 |
artikel |
17 |
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs: approval of nivolumab for unresectable advanced or recurrent epithelial skin malignancies in Japan
|
Matsumura, Noriomi |
|
|
29 |
6 |
p. 639 |
artikel |
18 |
Progressive changes in the protein expression profile of alveolar septa in early-stage lung adenocarcinoma
|
Kimura, Toru |
|
|
29 |
6 |
p. 771-779 |
artikel |
19 |
Psoas mass index at the level of the third lumbar vertebra on computed tomography is a prognostic predictor for metastatic castration-sensitive prostate cancer
|
Owa, Shunsuke |
|
|
29 |
6 |
p. 840-846 |
artikel |
20 |
Salivary gland-type cancers: cross-organ demographics of a rare cancer
|
Tanzawa, Aika |
|
|
29 |
6 |
p. 755-763 |
artikel |
21 |
SlicerPIT: software development and implementation for planning and image-guided therapy in photoimmunotherapy
|
Suzuki, Takayoshi |
|
|
29 |
6 |
p. 735-743 |
artikel |
22 |
Survival impact of sequential chemotherapy following pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma
|
Iwaki, Sho |
|
|
29 |
6 |
p. 764-770 |
artikel |
23 |
Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology
|
Tsuchihashi, Kenji |
|
|
29 |
6 |
p. 700-705 |
artikel |